Healthcare Services

ADME Toxicology Testing Market Global Report 2026 Market Outlook 2026–2030 Exploring New Business Opportunities

March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The ADME Toxicology Testing Market Over The 2026–2030 Period?

The adme toxicology testing market size has experienced rapid growth in recent years. It is forecast to expand from $11.5 billion in 2025 to $12.83 billion in 2026, at a compound annual growth rate (CAGR) of 11.6%. The historical period’s growth can be linked to the limited availability of automated adme testing systems, the reliance on traditional biochemical assays, a rising regulatory focus on drug safety, expanding pharmaceutical research initiatives, and the adoption of lc-ms and hplc instruments.

The adme toxicology testing market is projected to experience substantial expansion over the upcoming years, with its value set to reach $20.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.1%. This anticipated growth during the forecast period is driven by several factors, including the advancement of integrated ADME platforms, the expanding utilization of omics and molecular imaging technologies, increased capital allocation towards predictive toxicology software, the broadening scope of ADME testing within the cosmetics and food sectors, and the implementation of AI-powered risk assessment solutions. Key trends expected during this period encompass the increasing uptake of high-throughput screening instruments, a greater reliance on cell-based and in vitro assays, a surging demand for omics-based toxicology approaches, the wider application of ADME testing in pharmaceutical development, and the incorporation of simulation and modeling software into risk assessment processes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp

Which Economic Or Industry Drivers Are Impacting The ADME Toxicology Testing Market?

The increasing need for new therapeutic compounds is anticipated to fuel the expansion of the ADME toxicology testing market in the future. Novel drugs are pharmaceutical products that have not previously received approval or been introduced for medical use. ADME toxicity testing represents a crucial phase in drug development, designed to verify that these new medications are safe and do not generate adverse substances within the body. For example, in January 2024, the New Drug Therapy Approvals 2023 report from the Center for Drug Evaluation and Research (CDER), a US-based division of the U.S. Food and Drug Administration (FDA), indicated that the CDER sanctioned 55 novel drugs in 2023, 20 (36%) of which were categorized as first-in-class, an increase from 37 novel drug approvals in 2022. Consequently, the growing appetite for novel drugs is a key factor propelling the ADME toxicology testing market forward. The expanding pharmaceutical sector is projected to stimulate the ADME toxicology testing market’s future growth. This industry encompasses the discovery, formulation, and manufacturing of medications and drugs by both public and private organizations. The pharmaceutical industry employs ADME toxicology testing to determine the absorption, distribution, metabolism, and excretion (ADME) characteristics of potential drug compounds and to evaluate their possible toxic effects. Such testing is vital for forecasting a drug’s behavior within the human body, covering its absorption rates, spread to target areas, metabolic processing, and eventual removal. As an illustration, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade group representing the European pharmaceutical sector, reported that overall pharmaceutical production in Europe reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Thus, the expansion of the pharmaceutical industry is a significant impetus behind the ADME toxicology testing market’s rise.

How Is The ADME Toxicology Testing Market Segmented Across Key Categories?

The adme toxicology testing market covered in this report is segmented –

1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Product Types

2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo

3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies

4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations

2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software

3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays

4) By Reagents: Biochemicals, Buffer Solutions, Culture Media

5) By Other Products: Kits And Consumables, Analytical Standards

Which Upcoming Trends Are Expected To Influence The ADME Toxicology Testing Market?

Leading companies within the ADME toxicology testing market are incorporating advanced technologies, such as the Cyprotex e-Store, to facilitate the online ordering of ADME-Tox services. These ADME-Tox services aim to reduce development costs and timelines, minimize the likelihood of failure in later stages, and enable the selection of the optimal candidate for clinical development. For instance, in October 2023, Evotec SE, a Germany-based biotechnology company, introduced the Cyprotex e-Store, an e-commerce platform that provides simplified online access to its extensive range of ADME-Tox services. This e-Store streamlines and accelerates the buying process, allowing registered users to evaluate and order Cyprotex’ offerings continually, seven days a week. It offers immediate online access to prices and detailed protocols, enabling users to effortlessly place, track, and reorder services as needed. This efficient platform reduces the lead time for services, ensuring users receive their data more quickly.

Who Are The Dominant Players Shaping The ADME Toxicology Testing Market Landscape?

Major companies operating in the adme toxicology testing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

Read the full adme toxicology testing market report here:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

What Are The Top-Performing Regions Within The ADME Toxicology Testing Market?

North America was the largest region in the ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored ADME Toxicology Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11922&type=smp

Browse Through More Reports Similar to the Global ADME Toxicology Testing Market 2026, By The Business Research Company

pharma ADMET testing global market report

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

genetic toxicology testing global market report

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

in vitro toxicology testing global market report

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795